In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Portal Instruments, Inc.

https://www.portalinstruments.com

Latest From Portal Instruments, Inc.

Deals Shaping The Medical Industry, December 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance or Financing. This month’s column covers deals announced in November 2017.

Deals BioPharmaceutical

Deal Watch: Genentech Expands Upon Arvinas PROTAC Collaboration

The Roche affiliate doubles the potential monetary value of partnership focused on PROTAC technology in a range of therapeutic areas. Cardinal sells off Chinese business for $1.2bn, while Novartis licenses Homology’s gene-editing technology.

Deals Business Strategies

Profile: Katherine Bowdish, Sanofi’s Early Science Investment Scout

Katherine Bowdish, vice president of global R&D at Sanofi and leader of Sunrise, the French big pharma's early-stage investment arm, talks to Scrip about living vicariously through biotech companies whilst having the power and backing of a pharma major to advance important, innovative science.

StartUps and SMEs Market Intelligence

Deal Watch: Orexigen And Takeda Call It Quits, AbbVie And Boehringer Join Forces

AbbVie pays $595m up front for rights to Boehringer's Phase III anti-IL-23 candidate, which it sees as a potential competitor to Stelara. Merck and Sanofi end their European vaccines joint venture after a 22-year run.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
    • Drug Delivery
      • Macromolecule
      • Transdermal
  • Medical Devices
    • Consumables, Central Supplies
    • Implantable Devices
    • Infection Control-Sterilization
    • Infusion Therapy Equipment and Supplies
    • Laser
    • Monitoring Equipment & Devices
    • Radiofrequency Devices
    • Rehabilitation Equipment and Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Biotechnology
    • Large Molecule
UsernamePublicRestriction

Register